~~<i id='CCA2034443'><strike id='CCA2034443'><tt id='CCA2034443'><pre id='CCA2034443'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

knowledge

author：knowledge 2025-09-30 22:10:35 - browse：67588

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Superbugs, antibiotic resistance get scrutiny in congress

focus

leisure time

explore

focus

explore

leisure time

14:24BritneySpearsappearsatthe29thannualGLAADMediaAwardsinBeverlyHills,Calif.,April12,2018.ChrisPizz

WSS

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Germany receives 178 compensation applications from gay servicepeople over discrimination

Ohioans vote in high

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

leisure time

knowledge

focus

Affirmative action in medical school literally saved lives

After half a century, Israel moves to evict squatter from his cave home on the beach

Medicare details structure of new drug price negotiation program

Astronauts get first look at the spacecraft that will fly them around the moon

New air purifier tech could be key to improving indoor air quality

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Hepatitis C has a cure — but many Americans still lack access to it

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Wildfire smoke exposes gaps in outdoor worker protections

Sage's campaign to raise awareness of postpartum depression hits a nerve

leisure time

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Former Georgia lieutenant governor says he received grand jury subpoena

Hospitals use virtual reality to design more inclusive rooms for kids

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

China sends large group of warplanes, navy ships towards Taiwan in forceful display

explore

focus

explore

leisure time